Self-Made, Self-Disciplined And Ambitious
[email protected]23 Nov, 2021News
Satish Mehta, MD & CEO, Emcure Pharma is currently having a moment under the sun. Emcure?s subsidiary, Gennova, is developing India?s first indigenously developed mRNA COVID-19 vaccine that is currently undergoing phase II and phase III trials. Mehta is confident about meeting the said target of 60 million doses by the end of 2021, despite the logistics challenges. The company is working towards backward integration of its operations to help de-risk the supply chain.
Related Bookmarks
- Speech Therapy for Children North York At SpeechLink
- Why is Septic System Inspection in North York Important for Buyers?
- Chinese Medicine Petaluma
- Installation Solar
- Authorized Distributers of Ventilators in Middle East
- Online Baby Products
- Outstanding Interior Designing Services In Gurgaon By Matter Of Space!
- Shanghai Jewish Refugee Museum
- Bring Uniqueness Home By Hiring The Best Interior Designer In Gurgaon
- Punctuality: The Most Important Factors To Consider While Looking For Restaurant Vendors
Recent Profiles
Loeweoncloud
32win
S200
Danielcharli
Brandon Timmins
Kikivintage
Sunwin
Hi88casino
Luck8
Rahul Neelakanth